Search Results 21-30 of 28279 for Adenocarcinoma
Fields is the Monica Flynn Jacoby Professor of Cancer Research at Mayo Clinic. He and his team studied the molecular features of lung adenocarcinoma in mice and ...
... Adenocarcinoma (R-PDAC) as well as those with Resectable Pancreatic Ductal Adenocarcinoma (BR-PDAC) independently in response to neoadjuvant sequential ...
Find out about symptoms and causes for this cancer that starts in the large intestine. Learn about treatment options, including minimally invasive surgery.
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) · More about research at Mayo Clinic.
Establishing a Platform for Personalized Approach to the Management of Rectal Adenocarcinoma Using Patient-Derived Tumoroids and Organoids · Overview.
This phase II trial studies how well pembrolizumab works in treating patients with small bowel adenocarcinoma that has spread to other places in the body or ...
About this study. This phase II trial studies how well pembrolizumab works in treating patients with small bowel adenocarcinoma that has spread to other ...
Hilar cholangiocarcinoma is a type of bile duct cancer that occurs in the bile ducts that lead out of the liver (hepatic ducts) and join with the ...
... adenocarcinoma who are undergoing surgery. Immunotherapy with antibodies, such as nivolumab and ipilimumab, may remove the brake on the body's immune system ...
Participation eligibility · Patient must be ≥ 18 years of age · Two or more GGO's or solid lesions suspicious for multifocal disease. · Clinical diagnosis of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now and help create new and better solutions for more than 1.3 million patients who turn to Mayo Clinic each year.